Sinopia Biosciences, Inc. is a privately held biotechnology company headquartered in San Diego, California. Founded in 2014, the company focuses on advancing novel therapeutics discovered through its proprietary computational drug discovery platform.
Subscribe to see Sinopia Biosciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Sinopia Biosciences, Inc. is a company headquartered in United States. Its most recent funding round raised $2.8M in June 2026. Xcout tracks 8 named people at Sinopia Biosciences, Inc., including Iman Famili (COO).
2 more named people on record for Sinopia Biosciences, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $2.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Sinopia Biosciences, Inc.'s closest competitors — see the full list of competitors and alternatives →
Abilita Therapeutics, Inc. is a privately held biotechnology company founded in 2014 and focused on redefining therapeutics. The company is headquartered in San Diego, California.
cAMPfield Therapeutics is a biotechnology research company headquartered in San Diego, California. The company focuses on discovering and developing innovative therapeutic treatments targeting specific biological pathways.
ProNovo Therapeutics is a precision medicine company headquartered in San Diego, California, focused on developing targeted therapeutics.
Empirico Inc. is a drug discovery and development company headquartered in San Diego, California. It utilizes large biological datasets, human genetics, and programmable biology to discover novel therapeutics.
Principia Biopharma Inc. is a biopharmaceutical company headquartered in South San Francisco, California, focused on discovering and developing novel treatments.
Harmonic Discovery is a drug discovery company founded in 2021 and headquartered in New York City. The company leverages machine learning and precision pharmacology to develop therapeutics for complex diseases.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Sinopia Biosciences, Inc.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.